Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Taiwan Semiconductor
TSM
5
Apple
AAPL
US Stock MarketDetailed Quotes
ELTX Elicio Therapeutics
- 7.660
- -0.230-2.92%
Close Mar 10 16:00 ET
- 7.660
- 0.0000.00%
Post 16:00 ET
92.33MMarket Cap-1.76P/E (TTM)
7.880High7.575Low29.89KVolume7.880Open7.890Pre Close231.35KTurnover0.54%Turnover RatioLossP/E (Static)12.05MShares11.45052wk High-4.86P/B42.38MFloat Cap3.34252wk Low--Dividend TTM5.53MShs Float263.000Historical High--Div YieldTTM3.87%Amplitude2.960Historical Low7.740Avg Price1Lot Size
About Elicio Therapeutics Company
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Company Profile
SymbolELTX
Company NameElicio Therapeutics
Listing DateFeb 5, 2021
Founded2011
CEOMr. Robert Connelly
MarketNASDAQ
Employees32
Fiscal Year Ends12-31
Address451 D Street,5th floor, Suite 501
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-209-0050
Websitehttp://www.elicio.com
Company Executives
- Name
- Position
- Salary
- Robert Connelly
- Chief Executive Officer, President, Director, Principal Accounting Officer and Principal Financial Officer
- 678.30K
- Dr. Peter DeMuth, PhD
- Chief Scientific Officer
- --
- Dr. Christopher Haqq, M.D.,PhD
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- 673.82K
- Dr. Julian Ada PhD
- Chairman of the Board
- 96.05K
- Dr. Jay R. Venkatesan, M.D.
- Director
- 45.76K
- Yekaterina Chudnovsky
- Director
- 48.68K
- Dr. Allen R. Nissenson,M.D.
- Independent Director
- 91.22K
- Dr. Robert R. Ruffolo, Jr, Ph.D
- Independent Director
- 63.26K
- Karen J. Wilson
- Independent Director
- 101.02K
- Carol Gail Ashe
- Independent Director
- 71.59K